|
HY-145426-10mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-100mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-25mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-5mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-50mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-1mL
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-101287-10mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-100mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-25mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-5mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-50mg
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101287-1mL
|
MedChemexpress LLC
|
MPT0B392 [CAS 1346169-92-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-139181-1mg
|
MedChemexpress LLC
|
NR160 [CAS 2484895-50-1]
|
|
|
|
|
HY-N3121-10mg
|
MedChemexpress LLC
|
Pachypodol [CAS 33708-72-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N3121-5mg
|
MedChemexpress LLC
|
Pachypodol [CAS 33708-72-4]
|
|
Cancer-programmed cell death
|
|
|
HY-147027-10mg
|
MedChemexpress LLC
|
PARP-1-IN-2 [CAS 684234-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-147027-25mg
|
MedChemexpress LLC
|
PARP-1-IN-2 [CAS 684234-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-147027-5mg
|
MedChemexpress LLC
|
PARP-1-IN-2 [CAS 684234-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-147030-10mg
|
MedChemexpress LLC
|
PARP1-IN-8 [CAS 836640-15-4]
|
|
Cancer-programmed cell death
|
|
|
HY-147030-25mg
|
MedChemexpress LLC
|
PARP1-IN-8 [CAS 836640-15-4]
|
|
Cancer-programmed cell death
|
|
|
HY-147030-5mg
|
MedChemexpress LLC
|
PARP1-IN-8 [CAS 836640-15-4]
|
|
Cancer-programmed cell death
|
|
|
HY-N3062-1mg
|
MedChemexpress LLC
|
Pinobanksin [CAS 548-82-3]
|
|
|
|
|
HY-N3062-5mg
|
MedChemexpress LLC
|
Pinobanksin [CAS 548-82-3]
|
|
|
|
|
HY-147812-10mg
|
MedChemexpress LLC
|
POLA1 inhibitor 1 [CAS 2217671-41-3]
|
|
Cancer-programmed cell death
|
|
|
HY-147812-100mg
|
MedChemexpress LLC
|
POLA1 inhibitor 1 [CAS 2217671-41-3]
|
|
Cancer-programmed cell death
|
|
